New research in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging identifies a novel neural pathway to treat alcohol use disorder. This figure shows areas in which tolcapone, relative to ...
BOSTON, Nov. 12, 2025 /PRNewswire/ -- Modulight Biotherapeutics, developer of novel optogenetic platform for the treatment of neurological disorders, announced today the closing of its Seed funding ...
Stanford Medicine investigators have replicated, in a lab dish, one of humans' most prominent nervous pathways for sensing pain. This nerve circuit transmits sensations from the body's skin to the ...
The approval of this accelerated pathway not only demonstrates the FDA’s full recognition of the quality, safety, and efficacy of the Phase 1 clinical data of hNPC01 in China, but also will ...
A recent study published in the journal MedComm reviewed the potential role of the gut microbiota-brain axis (GBA) in neurological disorders. Microbiota is a crucial determinant of human health and ...
Neurofibromatosis type 1 (NF1) is an inherited neurological disorder that affects 1 in 3,500 people worldwide. It is caused by mutations in the NF1 gene, which encodes neurofibromin, a protein ...
The FDA clears ProlivRx at-home neuromodulation for adjunctive major depressive disorder treatment in adults with inadequate antidepressant response.
Stress worsens sleep quality and can impair memory. Shinjae Chung, from the University of Pennsylvania, led a study to explore a neural pathway in male mice that stress may influence to cause sleep ...
A new study published in Nature Neuroscience provides a detailed look at how the psychedelic drug psilocybin facilitates the unlearning of fear in the brain. The research reveals that the drug does ...
| Servier is committing to rare neurology for the long term, using focused science and strategic collaborations to bring new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback